News highlights the opening of the first unit of the Xeno BR project, which aims to allow the transplantation of organs from pigs to humans

The first advanced biotechnology laboratory of its kind in Brazil, Xeno BR will be essential for advancing research on organ transplantation from pigs to humans

Interview with the general coordinator of Genoma USP for the new international journal Genomic Psychiatry: Advancing the Science of Genes to Society

General coordinator of Genome USP was selected to be presented at the Scientist Spotlights Initiative, a project supported by the National Institutes of Health in the United States.

New Bloomberg Línea list includes 45 Brazilians who stand out for innovation in their areas, including the general coordinator of Genome USP

Genoma USP and other centers supported by the program are highlighted in the publication "Cutting Edge Research: Long-term funding (10+years) for multi-institutional research centers of excellence, in all areas of knowledge"

Statement discuss progress, promise, and challenges in research, regulation, and equitable development of human genome editing technologies and therapies.

Genoma USP investigated over-90s who were resilient to SARS-CoV-2 and identical twins who had severe COVID-19 with different outcomes, including long COVID

A team at Genoma USP investigated over-90s who were resilient to SARS-CoV-2 and identical twins who had severe COVID-19 with different outcomes, including long COVID

Universities, research institutions and agencies of the São Paulo State Government will join forces in 15 new centers announced during a ceremony held to celebrate FAPESP’s 60th anniversary. The centers will address problems in areas ranging from human and animal health to the energy transition and climate change

Whole-genome sequences of 1,171 elderly people living in São Paulo City were analyzed to detect mutations responsible for disease or that play a key role in healthy aging.

Whole-genome sequences of 1,171 elderly people living in São Paulo City were analyzed to detect mutations responsible for disease or that play a key role in healthy aging

Experiments conducted at HUG-CELL showed that besides directly combating tumor cells, zika alerted the immune system to the presence of cancer. The study opens up prospects for the use of virotherapy for central nervous system tumors.

The hypothesis was raised by scientists at HUG-CELL, on the basis of an epidemiological survey involving 1,744 Brazilian couples where at least one partner was infected

In a paper accepted for publication in Nature Immunology, researchers from HUG-CELL and colleagues with the COVID Human Genetic Effort propose several potential sites in the genome that could govern resistance to SARS-CoV-2

HUG-CELL researchers studied the case of identical twins in which only one sibling was reinfected and developed complications after a second exposure to the virus

HUG-CELL research suggest that more frequent variants in the resistant spouses could lead to more efficient activation of NK cells, which are part of the innate immune system, the first barrier against infection

A method created in Brazil by the Human Genome and Stem Cell Research Center could be used for large-scale production of livers for transplantation.

Analysis of DNA from 1,171 over-sixties living in São Paulo will enable scientists to identify genetic mutations responsible for diseases or important to healthy aging, according to the authors of the study

Findings reported by Brazilian researchers in PLOS Neglected Tropical Diseases help explain why only some babies whose mothers are infected during pregnancy are born with microcephaly and other anomalies.

The new tests are based on RT-LAMP, a molecular technique widely used to diagnose infectious diseases caused by RNA viruses such as dengue, chikungunya, hepatitis A and zika

A study is being conducted to determine whether people who develop severe forms of the disease have risk genes and whether asymptomatic people or patients with only mild symptoms have protective genes.

The dysregulation appeared to affect communication among neurons in the subjects of the study. The discovery could improve diagnosis, which is currently based on the clinical analysis of symptoms.

The viral therapy was tested in three elderly animals with spontaneous brain tumors by a group of researchers at the HUG-CELL